Finance News Network

Company Presentations

Telix Pharmaceuticals (ASX:TLX) Presentation, FNN Investor Event, May 2019, Sydney

30 May 2019 - Telix Pharmaceuticals Limited (ASX:TLX) CEO, Dr Christian Behrenbruch discusses the company’s development pipeline and the benefit of diagnostic and therapeutic produ…

Silver Mines (ASX:SVL) Presentation, FNN Investor Event, May 2019, Sydney

29 May 2019 - Silver Mines Limited (ASX:SVL) Managing Director, Anthony McClure presents on the company's Bowdens Silver & Barabolar Projects in the Central West of NSW at FNN's In…

Prescient Therapeutics (ASX:PTX) Presentation, FNN Investor Event, May 2019, Sydney

28 May 2019 - Prescient Therapeutics Limited (ASX:PTX) Managing Director & CEO, Steven Yatomi-Clarke discusses the company’s development pipeline, lead drug candidate PTX-200 and P…

Imugene (ASX:IMU) Presentation, FNN Investor Event, May 2019, Sydney

27 May 2019 - Imugene Limited (ASX:IMU) Managing Director & CEO, Leslie Chong presents on trial progress with the company's HER-B Vaxx cancer vaccines, the advantages of B-cell vac…

LaserBond (ASX:LBL) Presentation, FNN Investor Event, May 2019, Sydney

23 May 2019 - LaserBond Limited (ASX:LBL) CEO Wayne Hooper discusses the company's 1H19 results, how it reduces down-time and replacement costs on expensive machinery, investments …

DomaCom (ASX:DCL) Presentation, FNN Investor Event, May 2019, Sydney

16 May 2019 - DomaCom Limited (ASX:DCL) CEO Arthur Naoumidis presents on how the company's products make property investing more accessible, whereby people can invest in properties…

Tesserent (ASX:TNT) Presentation, FNN Investor Event, May 2019, Sydney

15 May 2019 - Tesserent Limited (ASX:TNT) CEO Julian Challingsworth talks about cybersecurity, the company's end-to-end solution, strategy and recent funding to drive growth at FNN…

Regeneus (ASX:RGS) Presentation, FNN Investor Event, May 2019, Sydney

15 May 2019 - Regeneus Limited (ASX:RGS) CEO Leo Lee presents on the company's 1H19 results, its portfolio of novel cell-based therapies, progress with its Phase 2 trial of Progenz…

Lake Resources (ASX:LKE) Presentation, May 2019

06 May 2019 - Lake Resources (ASX:LKE) Managing Director Steve Promnitz provides an update on its development of four lithium projects in the heart of the Lithium Triangle, which p…

La Trobe Financial Presentation, FNN Fund Manager Event, April 2019, Melbourne

07 May 2019 - La Trobe Financial Head of Distribution, Michael Watson presents on the company's long history in property lending and how its credit funds deliver investors capital-…

Anatara LifeSciences (ASX:ANR) Presentation, FNN Investor Event, April 2019, Sydney

30 Apr 2019 - Anatara Lifesciences Limited (ASX:ANR) CEO, Steven Lydeamore presents on the company's lead Gastrointestinal Reprogramming Product (GaRP) for Irritable Bowel Syndrome…

Flinders Investment Partners Presentation, FNN Fund Manager Event, April 2019, Melbourne

18 Apr 2019 - Flinders Investment Partners Portfolio Manager Richard Macdougall presents on the Flinders Emerging Companies Fund, its approach, largest positions, sector overweight…

MGM Wireless (ASX:MWR) Presentation, FNN Investor Event, April 2019, Sydney

18 Apr 2019 - MGM Wireless Limited (ASX:MWR) Chairman & CEO Mark Fortunatow presents on the company's smartphone safety device for children, 1H19 financials and expansion into the …

Dundas Global Investors Presentation, FNN Fund Manager Event, April 2019, Melbourne

17 Apr 2019 - Dundas Global Investors Senior Partner, Alan McFarlane presents on the Apostle Dundas Global Equity Fund, its objectives, approach to investing and the academic evide…

Ingenia Communities Group (ASX:INA) Presentation, FNN Investor Event, April 2019, Sydney

17 Apr 2019 - Ingenia Communities Group Limited (ASX:INA) CFO, Scott Noble presents on trends in seniors’ accommodation, the company's holiday parks and recent acquisitions at FNN'…

Concentrated Leaders Fund (ASX:CLF) Presentation, FNN Fund Manager Event, April 2019, Melbourne

17 Apr 2019 - Concentrated Leaders Fund (ASX:CLF) CEO & CIO, Dr David Sokulsky presents on the fund's objectives, approach and what investors can expect from a concentrated portfol…

Global Energy Ventures (ASX:GEV) Presentation, FNN Investor Event, March 2019, Sydney

16 Apr 2019 - Global Energy Ventures Limited (ASX:GEV) CEO and Executive Chairman, Maurice Brand presents the market for compressed natural gas (CNG), approval for the company's CN…

Genex Power (ASX:GNX) Presentation, FNN Investor Event, April 2019, Sydney

16 Apr 2019 - Genex Power Limited (ASX:GNX) Executive Director Simon Kidston presents on the company's renewable energy hub in far north Queensland, its new 50MW solar project sout…

Capital Property Funds Presentation, FNN Fund Manager Event, April 2019, Melbourne

15 Apr 2019 - Capital Property Funds Executive Director, Joe Christie presents on the company's special purpose metropolitan office and first mortgage funds at FNN's Fund Manager E…

DomaCom (ASX:DCL) Presentation, FNN Fund Manager Event, April 2019, Melbourne

15 Apr 2019 - DomaCom Limited (ASX:DCL) CEO Arthur Naoumidis presents on the company's range of innovative products, from direct ownership in commercial properties to buying proper…

Novatti Group (ASX:NOV) Presentation, FNN Investor Event, April 2019, Sydney

15 Apr 2019 - Novatti Group Limited (ASX:NOV) CEO, Peter Cook presents on the company's 1H19 results, growth in transaction processing and range of processing solutions, and provid…

Immutep (ASX:IMM) Presentation, Eftilagimod Alpha Clinical Development Update and New Data from Ongoing Melanoma Study, April 2019

08 Apr 2019 - Immutep Limited (ASX:IMM) CEO, Marc Voigt, CSO & CMO, Professor Frederic Triebel and Director Clinical Development and Regulatory Affairs, Christian Mueller, provide …